# Gut Microbiota and Bile Acids in Type 2 Diabetes Mellitus

> **NCT04194515** · — · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Metformin
- YH1

## Interventions

- **DRUG:** YH1
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT04194515
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04194515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04194515, "Gut Microbiota and Bile Acids in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04194515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*